Tower Research Capital LLC (TRC) - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 24 filers reported holding ADIAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$9,000
-18.2%
6,590
+24.6%
0.00%
Q1 2022$11,0005,289
+5467.4%
0.00%
Q3 2021$0
-100.0%
95
-79.5%
0.00%
Q2 2021$1,000
-66.7%
464
-66.0%
0.00%
Q1 2021$3,0000.0%1,365
-33.0%
0.00%
Q4 2020$3,000
-40.0%
2,036
-7.8%
0.00%
Q3 2020$5,000
+150.0%
2,209
+243.5%
0.00%
Q3 2018$2,0006430.00%
Other shareholders

There were no reported owners of ADIAL PHARMACEUTICALS INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of ADIAL PHARMACEUTICALS INC shareholders